Elon Musk announced Neuralink's plans for 2026, including the mass production of brain-computer interface chips and an almost fully automated surgical procedure for implantation. This advancement aims to make BCI technology more accessible, particularly for individuals with severe paralysis. The company received FDA approval in 2025 for speech restoration technology and achieved a $9 billion valuation.